Title Chronic Myelogenous Leukemia Patients with Highly Nilotinib-Resistant BCR-ABL Mutations Demonstrate Similar Efficacy to Dasatinib, but Have a Higher Likelihood of Developing New Mutations in the Event of Clinical Resistance
Authors Jiang, Qian
Qin, Ya-Zhen
Lai, Yue-Yun
Jiang, Bin
Jiang, Hao
Shi, Hong-Xia
Huang, Xiao-Jun
Affiliation Peking Univ, Inst Hematol, Peoples Hosp, Beijing Key Lab Hematopoiet Stem Cell Transplanta, Beijing 100871, Peoples R China.
Issue Date 2012
Publisher blood
Citation BLOOD.2012,120,(21).
URI http://hdl.handle.net/20.500.11897/308249
ISSN 0006-4971
Indexed SCI(E)
CPCI-S(ISTP)
Appears in Collections: 医学部待认领

Files in This Work
There are no files associated with this item.

Web of Science®


0

Checked on Last Week

百度学术™


0

Checked on Current Time




License: See PKU IR operational policies.